These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7195236)

  • 1. The comparison of the effects of AR-L 115 BS and dobutamine in patients with severe cardiac failure.
    Klein G; Sauer E; Bauer R; Wirtzfeld A; Sebening H
    Arzneimittelforschung; 1981; 31(1a):257-9. PubMed ID: 7195236
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of hemodynamic actions of pirbuterol and dobutamine on cardiac function in severe congestive heart failure.
    Awan NA; Needham KE; Evenson MK; Mason DT
    Am J Cardiol; 1981 Mar; 47(3):665-9. PubMed ID: 7468500
    [No Abstract]   [Full Text] [Related]  

  • 3. Onset and magnitude of cardiovascular response to dobutamine and AR-L 115 BS, a new positive inotropic agent with additional vasodilating activity, in normal subjects.
    Benedikter L; Mey T
    Arzneimittelforschung; 1981; 31(1a):239-42. PubMed ID: 7195230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of enoximone and catecholamines on renal function after open heart surgery].
    Zeplin HE
    Z Kardiol; 1991; 80 Suppl 4():59-62. PubMed ID: 1833899
    [No Abstract]   [Full Text] [Related]  

  • 5. Study of the acute effect of AR-L 115 BS, a new positive-inotropic agent in patients with exercise-induced heart failure.
    Drexler H; Wollschläger H; Löllgen H; Just H
    Arzneimittelforschung; 1981; 31(1a):259-62. PubMed ID: 7195237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New catecholamines in clinical cardiovascular medicine.
    Leier CV
    Kardiol Pol; 1980; 23(9):721-5. PubMed ID: 7441942
    [No Abstract]   [Full Text] [Related]  

  • 7. [Catecholamines in the therapy of chronic cardiac insufficiency].
    Brandt D; Klein W
    Wien Med Wochenschr; 1982 Oct; 132(19):450-6. PubMed ID: 6294999
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemodynamic effects of the new inotropic agent sulmazol (AR-L115 BS) administered intravenously to patients with severe heart failure.
    Hagemeijer F; van Mechelen R; Schelling A
    Herz; 1983 Feb; 8(1):41-6. PubMed ID: 6832692
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
    Burger AJ; Horton DP; LeJemtel T; Ghali JK; Torre G; Dennish G; Koren M; Dinerman J; Silver M; Cheng ML; Elkayam U;
    Am Heart J; 2002 Dec; 144(6):1102-8. PubMed ID: 12486437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Heart failure and acute myocardial infarct. Current treatment].
    Bernard R; Renard M
    Bull Mem Acad R Med Belg; 1983; 138(11):534-43. PubMed ID: 6679446
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparison of enoximone and dobutamine treatment on cardiac output after cardiac surgery].
    Lançon JP; Rerolle A; Parrot D; Obadia JF; Bock F; Caillard B
    Ann Fr Anesth Reanim; 1989; 8 Suppl():R230. PubMed ID: 2532487
    [No Abstract]   [Full Text] [Related]  

  • 12. [The effect of sodium nitroprusside and dobutamine on the ventricular myocardium in patients with severe left cardiac insufficiency].
    Cyran J; Bolte HD
    Verh Dtsch Ges Inn Med; 1978; (84):683-6. PubMed ID: 742099
    [No Abstract]   [Full Text] [Related]  

  • 13. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F
    Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
    De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F
    Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new orally active positive inotropic substance: AR-L 115 BS.
    Ruffmann KD; Mehmel HC; Kübler W
    Arzneimittelforschung; 1981; 31(1a):271-3. PubMed ID: 7195240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
    Aronson D; Burger AJ
    Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
    Rae AP; Tweddel AC; Hutton I
    Herz; 1983 Feb; 8(1):23-33. PubMed ID: 6832690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug regimens for congestive heart failure.
    Unverferth DV; Magorien RD; Leier CV
    Geriatrics; 1980 Jul; 35(7):26-33. PubMed ID: 7380254
    [No Abstract]   [Full Text] [Related]  

  • 19. A new non-glycoside, non-adrenergic cardiotonic agent AR-L 115 BS. Hemodynamic proof of its efficacy after both i.v. and oral administration.
    Thormann J; Kramer W; Schlepper M
    Arzneimittelforschung; 1981; 31(1a):273-8. PubMed ID: 7195241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemodynamic effects of dobutamine in the low-output cardiac syndrome].
    Pradella A; Codecà L; De Lorenzi E
    G Ital Cardiol; 1979; 9(7):763-6. PubMed ID: 540708
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.